Breathing treatment tested to stop fatal lung bleeds in critically ill cancer patients
NCT ID NCT05053867
Summary
This study is testing if a medicine called tranexamic acid, breathed in as a mist, can help control life-threatening lung bleeding in cancer patients who are on a breathing machine. It will compare this inhaled treatment to standard care to see if it improves survival at 28 days and helps stop the bleeding faster. The trial is for adults with blood cancers who are in intensive care with this serious complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.